The Short-term clinical observation of SIB-IMRT in locally advanced nasopharyngeal carcinoma
10.3760/cma.j.issn.1006-9801.2009.10.008
- VernacularTitle:同期推量调强放疗联合化疗治疗鼻咽癌的近期疗效观察
- Author:
Weiguo ZHU
;
Jihua HAN
;
Tao LI
;
Changhua YU
;
Jin PENG
;
Xilei ZHOU
- Publication Type:Journal Article
- Keywords:
Nasopharyngeal neoplasms;
Radiotherapy;
computer--assisted;
Drug therapy;
Prognosis
- From:
Cancer Research and Clinic
2009;21(10):671-673
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the feasibility , toxicity and clinical efficacy of intensity-modulated radiotherapy using the simultaneous integrated boost (SIB- IMRT) and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Methods Thirty nsopharyngeal carcinoma were treated with full course IMRT including nasopharynx and full neck to supraclavicle. The radiotherapy dosage is 68 Gy to the target. Concurrent chemotherapy was given, and the regimen was DDP 40 mg/m2/weekly.Results The mean dose of covering gross tumor volume(PGTV) (D95) in the nasopharynx was 70.48 Gy, and the mean volume of PGTV1 receiving the 95 % dose(V95) was 98. 46 %. The mean dose of PGTV1, PGTV2, PCTV1 and PCTV2 in the targets were 70.8 Gy, 66.4 Gy, 62.3 Gy and 54.8 Gy. According to the evaluation, the acute skin,mucositis and salivary toxicity with grade Ⅲ in those patients were 3.3 %, 10 %, 6.6 %. The patients developed different blood toxicity, but didn't affect their treatment. The median follow-up time was 6.5 months, and disease free survival rate was 100 %. Conclusion SIB-IMRT yields well dose distribution and acceptable toxicity in advanced stage nasopharyngeal carcinoma. The preliminary clinical result is encouraging.
